← Back to Search

Wearable Biosensor Accuracy for Alcohol Intoxication

N/A
Recruiting
Led By Catharine Fairbairn, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
21 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from beginning to end of alcohol administration visit, measured every ten minutes, up to 12 hours
Awards & highlights

Study Summary

This trial will track participants' alcohol use over 14 days with sensors and breathalyzers, and involve 3 lab sessions to assess alcohol dose/rate of consumption.

Who is the study for?
This trial is for individuals who are at least 21 years old and drink alcohol at least twice a week. It's not suitable for those with medical or psychological conditions that make drinking unsafe, people currently treating an alcohol use disorder, pregnant women, or anyone taking medications that interact badly with alcohol.Check my eligibility
What is being tested?
The study tests the accuracy of new wearable biosensors in measuring blood alcohol content (BAC). Participants will wear these sensors over two weeks while providing breathalyzer data during real-world drinking and controlled lab sessions where their drinking amounts vary.See study design
What are the potential side effects?
Since the intervention involves consuming alcohol, potential side effects include typical reactions to intoxication such as impaired coordination, dizziness, nausea, vomiting, hangovers, and in severe cases acute alcohol poisoning.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from beginning to end of alcohol administration visit, measured every ten minutes, up to 12 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and from beginning to end of alcohol administration visit, measured every ten minutes, up to 12 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Ambulatory Breath Alcohol Concentration
Change in Breath Alcohol Concentration During Laboratory Visits

Side effects data

From 2017 Phase 2 trial • 17 Patients • NCT01779024
59%
Increased Appetite
41%
Somnolence
35%
Euphoric mood
29%
Fatigue
12%
Hyperhidrosis
12%
Memory impairment
12%
Dizziness
12%
Nausea
6%
Headache
6%
Feeling hot
6%
Flushing
6%
Decreased appetite
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ghrelin
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Group I: Slow ConditionExperimental Treatment1 Intervention
Participants randomized to consume study beverages at a comparatively slow rate.
Group II: Fast ConditionExperimental Treatment1 Intervention
Participants randomized to consume study beverages at a comparatively rapid rate.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcohol
2008
Completed Phase 3
~2000

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,930,556 Total Patients Enrolled
University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,095 Total Patients Enrolled
Catharine Fairbairn, PhDPrincipal InvestigatorUniversity of Illinois Urbana-Champaign

Media Library

Fast Condition Clinical Trial Eligibility Overview. Trial Name: NCT05692830 — N/A
Alcohol Consumption Research Study Groups: Fast Condition, Slow Condition
Alcohol Consumption Clinical Trial 2023: Fast Condition Highlights & Side Effects. Trial Name: NCT05692830 — N/A
Fast Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05692830 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many research participants are enrolled in this trial?

"Affirmative. The information on clinicaltrials.gov suggests that this medical investigation is currently enlisting participants, with its first publication being April 3rd 2022 and last update occurring January 19th 2023. A total of 240 volunteers are necessary between a single site."

Answered by AI

Is this scientific investigation currently enrolling participants?

"Yes, the details available on clinicaltrials.gov confirm that this medical study is actively recruiting participants. The trial was initially posted on April 3rd 2022 and has since been updated as recently as January 19th 2023. A total of 240 patients need to be recruited from 1 site for successful completion of the experiment."

Answered by AI
~132 spots leftby Aug 2026